- Home
- AAPG vs TENB Comparison
AAPG vs TENB Comparison
Compare AAPG & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- TENB
- Stock Information
- Founded
- AAPG 2009
- TENB 2002
- Country
- AAPG China
- TENB United States
- Employees
- AAPG N/A
- TENB N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- TENB Computer Software: Prepackaged Software
- Sector
- AAPG Health Care
- TENB Technology
- Exchange
- AAPG Nasdaq
- TENB Nasdaq
- Market Cap
- AAPG 3.6B
- TENB 3.6B
- IPO Year
- AAPG 2025
- TENB 2018
- Fundamental
- Price
- AAPG $34.61
- TENB $30.49
- Analyst Decision
- AAPG Buy
- TENB Buy
- Analyst Count
- AAPG 1
- TENB 17
- Target Price
- AAPG N/A
- TENB $40.69
- AVG Volume (30 Days)
- AAPG 7.0K
- TENB 1.1M
- Earning Date
- AAPG 11-19-2025
- TENB 10-29-2025
- Dividend Yield
- AAPG N/A
- TENB N/A
- EPS Growth
- AAPG N/A
- TENB N/A
- EPS
- AAPG N/A
- TENB N/A
- Revenue
- AAPG $54,524,554.00
- TENB $949,251,000.00
- Revenue This Year
- AAPG N/A
- TENB $11.66
- Revenue Next Year
- AAPG $368.64
- TENB $7.86
- P/E Ratio
- AAPG N/A
- TENB N/A
- Revenue Growth
- AAPG N/A
- TENB 11.41
- 52 Week Low
- AAPG $16.50
- TENB $28.51
- 52 Week High
- AAPG $48.45
- TENB $45.45
- Technical
- Relative Strength Index (RSI)
- AAPG 39.44
- TENB 56.96
- Support Level
- AAPG $33.12
- TENB $29.73
- Resistance Level
- AAPG $35.49
- TENB $30.67
- Average True Range (ATR)
- AAPG 0.97
- TENB 0.64
- MACD
- AAPG -0.22
- TENB 0.16
- Stochastic Oscillator
- AAPG 20.89
- TENB 90.16
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.